Woodline Partners »

Phathom Pharmaceuticals shares owned by Woodline Partners

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Woodline Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.7M 740k 10.37
2023-06-30 $9.6M 674k 14.32
2021-09-30 $960k 30k 32.10
2021-03-31 $1.6M 42k 37.55